Amylyx Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Amylyx Pharmaceuticals (AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
March 30, 2022 4:51 PM EDT(Updated - March 30, 2022 4:51 PM EDT)
Amylyx Pharmaceuticals (NASDAQ: AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
... MoreAmylyx Pharmaceuticals (AMLX) Confirms Shares Halted Ahead of FDA Advisory Committee Meeting to Discuss NDA for AMX0035 for the Treatment of ALS
March 30, 2022 7:07 AM EDTAmylyx Pharmaceuticals (NASDAQ: AMLX) today announced that Nasdaq has halted trading of the companys common stock.
The U.S. Food and Drug Administrations (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) is meeting today to review the New Drug Application... More
